Skip to main content
OpenTrials

Clinical trial condition

Medulloblastoma

Explore clinical trials studying Medulloblastoma. Study availability and eligibility vary by location and protocol.

88 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Medulloblastoma trial results

Completed

p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

NCT01975116

Conditions
Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Astrocytoma, +28 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View Trial Details
Completed

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

NCT01125800

Conditions
Astrocytoma, Disease Attributes, Glioma, +21 more
Locations
  • Children's Healthcare of Atlanta Childern Hosp - ATL Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. John Hopkins Baltimore, Maryland, United States
  • Dana Farber Cancer Institute DFCI (3) Boston, Massachusetts, United States
  • Seattle Children's Hospital CPKC412A2114 Seattle, Washington, United States
View all 14 locations
View Trial Details
Completed

Combination of Irinotecan and Temozolomide in Children With Brain Tumors.

NCT00404495

Conditions
Glioma, Medulloblastoma, Neoplasms, +7 more
Locations
  • Pfizer Investigational Site Westmead, New South Wales, Australia
  • Pfizer Investigational Site Herston, Queensland, Australia
  • Pfizer Investigational Site Parkville, Victoria, Australia
  • Pfizer Investigational Site Ghent, Belgium
View all 29 locations
View Trial Details
Completed

A Study of Pemetrexed in Children With Recurrent Cancer

NCT00520936

Conditions
Ependymoma, Glioma, Medulloblastoma, +24 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Arcadia, California, United States
View Trial Details
Suspended

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

NCT06639607

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +24 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions